Fludalym should be administered under the supervision of a qualified doctor experienced in cancer therapy.
The dose given depends on the size of the patient's body. It varies with body surface area. Technically this is measured in square metres (m2), but actually is worked out from the height and weight. The recommended dose is 25 mg/m2 body surface. This will be given either as an injection or as an infusion (with a drip) into a vein once a day for 5 consecutive days every 28 days.
This five day course of treatment will be repeated every 28 days until the doctor has decided that the best effect has been achieved.
The dosage may be decreased or the repeat course delayed if side effects are a problem. If the patient has kidney problems, he/she will receive a reduced dose and will have regular blood tests.
The safety of this drug in children and adolescents below age 18 has not been established and treatment is not recommended.
If any of the Fludalym solution comes into contact with the skin or skin lining of the nose or mouth, wash the area thoroughly with soap and water. If the solution gets into the eyes, rinse them thoroughly with lots of water. Try not to breathe in any fumes coming from the solution.
If the patient forgets to use Fludalym: The doctor will set the times at which the patient is to receive this medicine. If the patient thinks that he/she may have missed a dose, contact the doctor as soon as possible.
If the patient has any further questions on the use of this product, ask the doctor or pharmacist.